Chris A. Rallis - 24 Jul 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A. Rallis
Issuer symbol
FENC
Transactions as of
24 Jul 2023
Net transactions value
-$55,523
Form type
4
Filing time
24 Jul 2023, 17:04:32 UTC
Previous filing
06 Jul 2023
Next filing
18 Aug 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Options Exercise $12,000 +16,666 +49% $0.7200* 50,772 24 Jul 2023 Direct F1
transaction FENC Common Shares Sale $55,523 -6,796 -13% $8.17 43,976 24 Jul 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Common Shares Options Exercise $12,000 -16,666 -8.2% $0.7200* 187,312 24 Jul 2023 Options 16,666 $0.7200 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares acquired through the exercise of an option contract with strike price of $0.72 and an expiration date of August 23, 2023.
F2 Shares sold to satisfy tax obligation on option exercise.
F3 Represents options granted on August 23, 2013, with a strike price of $0.72 and an expiration date of August 23, 2023.